The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders

Haematologica

Volumn 83, Issue 1, 1998, Pages 3-7

  Del Cañizo, Ma Consuelo ^a   Brufau, Ana ^a   Mota, Alexandra ^a   Lopez, Natalia ^a   Fernandez, Ma Eugenia ^a   Vallejo, Carlos ^a   Hernandez, Jesus Maria ^a   Garcia, Juan Luis ^a   San Miguel, J Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Atypical chronic myeloid leukemia; Cell cultures; Mixed myelodysplastic myeloproliferative disorders

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL CULTURE; CELL KINETICS; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL TRIAL; COLONY FORMATION; CYTOGENETICS; CYTOKINE PRODUCTION; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRELEUKEMIA; REFRACTORY ANEMIA;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS;

EID: 0031907444     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kouides PA, Bennet JM. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 1996; 33:95-110.
2. San Miguel JF, Sanz GF, Vallespí T, del Cañizo MC, Sanz MA. Myelodysplastic syndromes. Crit Rev Oncol Hematol 1996; 23:57-93.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99.
4. Verhoef GEG, Pittaluga S, de Wolf Peters C, Boogaerts MA. FAB classification of myelodysplastic syndromes: merits and controversies. Ann Hematol 1995; 71:3-11.
5. Rosati S, Mick R, Xu F, et al. Refractory cytopenia with multilineage dysplasia: further characterization of an "unclassifiable" myelodysplastic syndrome. Leukemia 1996; 10:20-6.
6. Del Cañizo MC, Sanz G, San Miguel JF, et al. Chronic myelomonocytic leukemia. Clinicobiological characteristics: A multivariate analysis of 70 cases. Eur J Haematol 1989; 42:466-73.
7. Ribera JM, Cervantes F, Rozman C. A multivariate analysis of prognostic factors in chronic myelomonocytic leukemia according to the FAB criteria. Br J Haematol 1987; 65:307-14.
8. Michaux JL, Martiat P. Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome? Leuk Lymphoma 1993; 9:35-41.
9. Ohyashiki K, Yokoyama K, Kimura Y, et al. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? Leukemia 1993; 7:338-40.
10. Verhoef GEG, Demuynck H, Zachee P, Boogaerts MA. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? Leukemia 1994; 8:714-5.
11. Rosati S, Anastasi J, Vardiman J. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol 1996; 33:111-26.
12. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid and chronic myelomonocytic leukaemia. Proposals by the FAB cooperative leukaemia group. Br J Haematol 1994; 87:746-54.
13. Oscier DG. Atypical chronic myeloid leukemia, a distinct clinical entity related to myelodysplastic syndrome? Br J Haematol 1996; 92:582-6.
14. Neuwirtová R, Mociková K, Musilová J, et al. Mixed myelodysplastic and myeloproliferative syndromes. Leuk Res 1996; 20:717-26.
15. Greenberg P. In vitro marrow culture studies in myelodysplastic syndromes. Semin Oncol 1992; 19:34-46.
16. Iscove NN, Sieher K, Witerhalter KH. Erythroid colony formation in culture of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concavalin. Am J Cell Physiol 1974; 83:309-20.
17. Minden MD, Till JE, McCulloch EA. Proliferation state of blast progenitors in acute myeloblastic leukemia (AML). Blood 1978; 52:592-600.
18. Del Cañizo MC, Mota A, Orfao A, et al. Value of CFU-GM assay in predicting relapse in acute myeloid leukemia. J Clin Pathol 1996; 49:450-2.
19. Hernández JM, Mecucci C, Beverloo B, et al. Translocation t(11;15) (q23,q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. Leukemia 1995; 9:1162-6.
20. Mittelman F. ISCN An International system for human cytogenetic nomenclature. F. Mittelman, ed. Basel:S. Karger, 1995.
21. Geissler K, Hinterberger W, Bettelheim P. Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res 1988; 12:373-7.
22. Felman P, Bryon PA, Gentilhomme O, et al. The syndrome of abnormal chromatin clumping in leucocytes: a myelodysplastic disorder with proliferative features? Br J Haematol 1988; 70:49-54.
23. Greenberg PL. Biological and clinical implications of marrow culture studies in the myelodysplastic syndromes. Semin Hematol 1996; 33:163-75.
24. Reid CDL. The significance of endogenous erythroid colonies (EEC) in haematological disorders. Blood Rev 1987; 1:133-40
25. nd ed. NewYork:Wiley-Liss, 1995.
26. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996; 33:127-38.
27. Gallagher A, Darley RL, Padua R. The molecular basis of myelodysplastic syndromes. Haematologica 1997; 82:191-204.
28. Jaén A, Irriguible D, Millá F, et al. Abnormal chromatin clumping in leucocytes: a clue to a new subtype of myelodysplastic syndrome. Eur J Haematol 1990; 45:209-14
29. Boulwood J, Lewis S, Wainscoat JS. The 5q- syndrome. Blood 1994; 84:3253-60.
30. Sacchi S, Russo D, Awisati G, et al. All-trans retinoic acid in hematological malignancies, an update. Haematologica 1997; 82:106-21.
31. Rigolin GM, Cuneo A, Roberti MG. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization. Haematologica 1997; 82:25-30.